Fig. 4From: Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET a Correlation analysis between the T/N ratios of 18F-FAMT PET and 18F-FDG PET showed significant positive correlation in all gliomas (r s = 0.430, p < 0.01). b Comparison of the T/N ratios of 18F-FAMT PET and 18F-FDG PET found significant differences for each WHO grade (all p < 0.05)Back to article page